Cite
10: NCI Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG/RTOG 0526)
MLA
Mahul B. Amin, et al. “10: NCI Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG/RTOG 0526).” Radiotherapy and Oncology, vol. 150, Sept. 2020, p. S8. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2de4c9fae68f1f8719a1bd2354ceca89&authtype=sso&custid=ns315887.
APA
Mahul B. Amin, Edouard J. Trabulsi, Peter J. Rossi, William S. Bice, Jeff M. Michalski, Howard M. Sandler, Thomas M. Pisansky, David C. Beyer, Eric M. Horwitz, J. Rodgers, Nadeem Pervez, Gerard Morton, Charles Catton, Juanita Crook, Viroon Donavanik, Mack Roach, & Eric Vigneault. (2020). 10: NCI Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG/RTOG 0526). Radiotherapy and Oncology, 150, S8.
Chicago
Mahul B. Amin, Edouard J. Trabulsi, Peter J. Rossi, William S. Bice, Jeff M. Michalski, Howard M. Sandler, Thomas M. Pisansky, et al. 2020. “10: NCI Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG/RTOG 0526).” Radiotherapy and Oncology 150 (September): S8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........2de4c9fae68f1f8719a1bd2354ceca89&authtype=sso&custid=ns315887.